Movement disorders, such as Parkinson's disease, essential tremor, and dystonia, are
characterized by their predominant motor symptoms, yet diseases causing abnormal …

Neuromelanin-sensitive MRI is a burgeoning non-invasive neuroimaging method with an
increasing number of applications in psychiatric research. This MRI modality is sensitive to …

Assessing imaging biomarker in the prodromal and early phases of Parkinson's disease
(PD) is of great importance to ensure an early and safe diagnosis. In the last decades …

While neuropathological studies have long made it abundantly clear that Parkinson's
disease extends beyond degeneration of dopaminergic neurons, it has not been until …

Background Deep brain stimulation of the subthalamic nucleus (STN-DBS) is a successful
treatment option in Parkinson's disease (PD) for different motor and non-motor symptoms …

Introduction: Increased theta and delta power and decreased alpha and beta power,
measured with quantitative electroencephalography (EEG), have been demonstrated to …

Introduction Parkinson's disease (PD) encompasses a range of non-motor symptoms
attributed to deficits in various neurotransmitter systems. This study aimed to investigate the …

Depression in Parkinson's disease (PD) is common, disabling and has poor outcomes.
Dopamine has a well-established role in both reward and motivational pathways. The …

抄録 統合失調症治療薬である向精神薬による薬剤誘発性運動疾患 (medication–induced
movement disorders: MIMD) について, 関連する脳神経内科疾患の画像を引用しながら治療方策 …